Twelve-year follow-up of omalizumab therapy for anaphylaxis in 2 patients with systemic mastocytosis

Authors:

Abstract
No abstract available
Funding Information
  • Division of Intramural Research, National Institutes of Health, National Institute of Allergy and Infectious Diseases

This publication has 9 references indexed in Scilit: